The use of a drug screening service has been investigated over a nine month period during which 1500 urine samples from 765 patients were analysed. Preliminary drug screening of urine samples was performed by EMIT immunoassays adapted for use on the Cobas Bio analyser; further identification and confirmation were carried out by Ton-Lab thin-layer chromatography and capillary gas chromatography. A large number of positive results were obtained for benzodiazepines, cannabinoids, methadone and opiates (mainly dihydrocodeine). Only a limited number of urines gave positive results for amphetamine and related stimulants; cocaine metabolite was rarely detected in samples. The service proved to be of considerable value in the management of drug misusers, and for the identification of new substances taken by the local population.
Editorial. Screening for drugs of abuse. Lancet1987; i: 365–366.
2.
SkidmoreCARobertsonJRSimpsonDJarvieDR. Toxicological screening in heroin users: complications for management of drug misuse. JRCGP1987; 37: 397–399.
3.
GreenwoodJ.Persuading general practitioners to prescribe - good husbandry or a recipe for chaos?Br J Addict1992; 87: 567–575.
4.
RobertsonJRSkidmoreCARobertsJJK. The dynamics of an illicit drug scene. Scot Med J1988; 33: 293.
5.
PeatMA. Analytical and technical aspects of testing for drug abuse: confirmatory procedures. Clin Chem1988; 34: 471–473.
6.
De CresceRMaguraALifshitzMTilsonJ.Drug testing in the workplace. Chicago: American Society of Clinical Pathologists, 1989; 118–121.
7.
HillPGMooreRA eds. Drugs of abuse screening: The requirements and provision of a laboratory service. London: The Association of Clinical Biochemists, 1988.
8.
MullenJBrachaHS. Toxicology screening - How to assure accurate results. Postgrad Med1986; 84: 141–148.
9.
MikkelsonSLAshKO. Adulterants causing false negatives in illicit drug testing. Clin Chem1988; 34: 2333–2336.
10.
WarnerA.Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin Chem1989; 35: 649–651.
11.
LafoliePBeckOBlennowGImportance of creatinine analysis of urine screening for abused drugs. Clin Chem1991; 37: 1927–1931.
12.
ElsohlyMNElsohlyMAStanfordDF. Poppy seed ingestion and opiates urinalysis: a closer look. J Anal Toxicol.1990; 14: 308–310.
13.
SelavkaCM. Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: the Pacific perspective. J For Sci1991; 36: 685–696.
14.
SiegelRKElsohlyMAPlowmanTCocaine in herbal tea. JAMA1986; 255: 40(L).
15.
MooreFMLSimpsonD.Detection of opiates in urine: a cost-effective low risk immunoassay procedure. Med Lab Sciences1989; 46: 309–312.
16.
MooreFMLSimpsonD.Detection of benzoylecgonine (cocaine metabolite) in urine: a cost-effective low risk immunoassay procedure. Med Lab Sciences1990; 47: 85–89.
17.
MooreFMLSimpsonD.Detection of cannabinoids in urine: a cost-effective low risk immunoassay procedure. Med Lab Sciences1991; 48: 76–79.
18.
MooreFMLJarvieDRSimpsonD.Urinary amphetamines, benzodiazepines and methadone; cost-effective detection procedures. Med Lab Sciences1992; 49: 27–33.
19.
RobertsonJRBuchnallABVWelsbyPDRobertsJJKInglisJMPeuthererJFBrettleRP. Epidemic of AIDS-related virus (HTLV-111/LAV) infection covering intravenous drug abusers. BMJ1986; 292: 527–529.
20.
KobayaskiHTzazukiMKoshimizuKSusceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol1984; 20: 214–216.
21.
ResnickLVerenKSalahuddinSTandreauSMarkhamP.Stability and inactivation of HTLV-111/LAV under clinical and laboratory environments. JAMA1986; 255: 1887–1891.
22.
MooreFMLSimpsonD.Heating drug-assay samples to minimise AIDS risk. Clin Chem1988; 34: 646(L).
23.
SimpsonDJarvieDRHeyworthR.An evaluation of six methods for the detection of drugs of abuse in urine. Ann Clin Biochem1989; 26: 172–181.
24.
KunsmanGWMarinoJECockerhamKRMannoBR. Application of Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethamphetamine (MDEA) in urine. J Anal Tox1990; 14: 149–153.
25.
SkidmoreCARobertsonJRRobertsonA AEltonRA. After the epidemic: follow-up study of HIV seroprevalence and changing patterns of drug use. BMJ1990; 300: 219–223.
26.
SutheimerCAYarboroughRHeplerBRSunshineI.Detection and confirmation of urinary cannabinoids. J Anal Toxicol1985; 9: 156–160.
LevineBSmithML. Stability of drugs of abuse in biological specimens. For Sc Rev1990; 2: 148–156.
29.
Perez-ReyesMDi GuiseppiSDMasonAPDavidKH. Passive inhalation of marijuana smoke and urinary excretion of cannabinoids. Clin Pharm Ther1983; 34: 36–41.
30.
SunshineI.Monograph: Marijuana (THC). Kansas City, Missouri: Analytical Division of Marion Laboratories inc. 1985.
31.
SchwartzRHHawksRL. Laboratory detection of marijuana use. JAMA1985; 254: 788–792.
32.
Common Services Agency for the Scottish Health Service. Scottish Drug Misuse Database Statistics. Edinburgh: Common Services Agency for the Scottish Health Service1992.
33.
KauffmanRE. Drug assays in the office. J Pediat1990; 116: 268–270.
34.
WolffKShanabMASandersonMJKayAWM. Screening for drugs of abuse: effect of heat-treating urine for safe handling of samples. Clin Chem1990; 36: 908–910.
35.
CresceRDrMaguraALifshitzMTilsonJ.Drug testing in the workplace. Chicago: American Society of Clinical Pathologists, 1989; 103–128.
36.
Syva Company. Frequently asked questions about Syva's EMIT drug abuse tests. Palo Alto, California: Syva Company, 1990.
37.
FinkleBSBlackDBlankeRVAnalysis for commonly abused drugs in urine at selected threshold (“cutoff”) concentrations. Clin Chem1991; 37: 586–587.
38.
CresceRDrMazuraALifshitzMTilsonJ.Drug testing in the Workplace. Chicago: American Society of Clinical Pathologists, 1989: 223–254.
39.
GhodseASheshanMTaylorCEdwardsG.Deaths of drug addicts in the United Kingdom 1967–81. BMJ1985; 290: 425–428.
